Business
Is the CSL (ASX:CSL) share price on the road to recovery?
The CSL Limited (ASX: CSL) share price has rebounded strongly since hitting a 52-week low of $242.00 in early March. The company is pushing forward with its locally manufactured COVID-19 vaccine rollout and implementing initiatives to restore plasma collections levels.
By yesterday’s market close, the global biotech’s shares finished the day 1.4% higher at $269.83.
With the latest developments, is the CSL share price finally on the road to recovery? Let’s take a look at what’s been happening for the biotech giant.
Vaccine update
Investors have buying CSL shares ahead of renewed optimism that the worst is behind the company.
According to the Australian Therapeutic Goods Administration (TGA), the first four batches of…
-
Noosa News4 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
Noosa News11 hours agoFarmer Fred Perry’s 30-year conservation project creates bird haven after years of ‘bashing and burning’
-
General10 hours agoBoy dies after being trapped between rocks off NSW beach
-
Noosa News11 hours agoDetectives continue to search for answers on Crystal Beale’s death